MS Relapse Rates Drop to Zero Following Stem Cell Transplants — But ‘Risks Are Real,’ Study Says
- People with multiple sclerosis (MS) who undergo hematopoietic stem cell transplantation (HSCT) may reduce their rate of relapse, according to a recent study.
- Researchers found that annual relapse rates dropped from 1.1 per person to zero following HSCT.
- The risks of stem cell transplantation were highest among participants with a high number of disabilities at the time of the procedure.
Read the full article here:
https://www.mymsteam.com/news/ms-relapse-rates-drop-to-zero-following-stem-cell-transplants-but-risks-are-real-study-says
Disclaimer: Content on our site is provided for information purposes only; therefore, this material is not intended to advise. This information includes a link to a site that is maintained by another; MS Monterey is not responsible for content on this site. Please remember to consult with your doctor or health care provider before making any changes to your medication(s) or medical regimen.